Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Impact of the Initial Admission Department on the Management and Prognosis of Retinal Artery Occlusion

Author(s): Yanqin Liu, Shuju Dong, Yaxi Luo, Yanbo Li, Changling Li, Dong Zhou* and Li He*

Volume 19, Issue 5, 2022

Published on: 29 November, 2022

Page: [440 - 448] Pages: 9

DOI: 10.2174/1567202620666221027091249

Price: $65

Abstract

Background: Retinal artery occlusion (RAO) is an emergency condition in both neurology and ophthalmology departments. However, RAO's management and visual outcome in different initial departments remain unclear. Therefore, we aimed to investigate the impact of the initial department on the management and prognosis of RAO.

Methods: Consecutive cases of RAO between January 2011 and December 2021 were retrospectively analyzed. The neurology and ophthalmology departments compared the baseline characteristics, relevant evaluation, and treatment. The primary outcome was the visual recovery rate. The secondary outcomes were newly diagnosed cardiovascular factors, concurrent stroke and new-onset cardiovascular events.

Results: A total of 74 RAO patients were included. The median age was 54 years, and 67.6% were male. 42 (56.8%) patients were admitted to the neurology department and 32 (43.2%) to the ophthalmology department. The visual recovery rate was higher in the neurology department than in the ophthalmology department, although the difference did not reach statistical significance (27.8 vs. 12.5%, p = 0.120). Risk factor evaluation and secondary prevention were taken more frequently in the neurology department (p < 0.001). Cardiovascular risk factors and concurrent stroke were all discovered in the neurology department. However, the incidence of new-onset cardiovascular events was similar between the two departments.

Conclusion: The study demonstrated that the visual prognosis of RAO was devastating regardless of the neurology and ophthalmology department. Given the admission delay, inadequate management, and high risk of cardiovascular risk factors and stroke, stroke centers should be recommended as initial admission departments for RAO patients.

« Previous Next »
[1]
Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal and ophthalmic artery occlusions preferred practice pattern®. Ophthalmology 2020; 127(2): P259-287.
[http://dx.doi.org/10.1016/j.ophtha.2019.09.028] [PMID: 31757501]
[2]
Kim J, Byun SJ, Woo SJ, Park KH, Park SJ. Assessment of trends in the incidence rates of central retinal artery occlusion in Korea from 2002 to 2015. JAMA 2015; 139(4): 399.
[http://dx.doi.org/10.1001/jamaophthalmol.2020.6860]
[3]
Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 2011; 152(5): 820-3.e2.
[http://dx.doi.org/10.1016/j.ajo.2011.05.005] [PMID: 21794842]
[4]
Hayreh SS, Zimmerman MB. Central retinal artery occlusion: Visual outcome. Am J Ophthalmol 2005; 140(3): 376.
[http://dx.doi.org/10.1016/j.ajo.2005.03.038] [PMID: 16138997]
[5]
Schrag M, Youn T, Schindler J, Kirshner H, Greer D. Intravenous fibrinolytic therapy in central retinal artery occlusion. JAMA Neurol 2015; 72(10): 1148-54.
[http://dx.doi.org/10.1001/jamaneurol.2015.1578] [PMID: 26258861]
[6]
Avery MB, Magal I, Kherani A, Mitha AP. Risk of stroke in patients with ocular arterial occlusive disorders: A retrospective canadian study. J Am Heart Assoc 2019; 8(3): e010509.
[http://dx.doi.org/10.1161/JAHA.118.010509] [PMID: 30712440]
[7]
Callizo J, Feltgen N, Pantenburg S, et al. Cardiovascular risk factors in central retinal artery occlusion. Ophthalmology 2015; 122(9): 1881-8.
[http://dx.doi.org/10.1016/j.ophtha.2015.05.044] [PMID: 26231133]
[8]
Hong JH, Sohn SI, Kwak J, et al. Retinal artery occlusion and associated recurrent vascular risk with underlying etiologies. PLoS One 2017; 12(6): e0177663.
[http://dx.doi.org/10.1371/journal.pone.0177663] [PMID: 28570629]
[9]
Lavin P, Patrylo M, Hollar M, Espaillat KB, Kirshner H, Schrag M. Stroke risk and risk factors in patients with central retinal artery occlusion. Am J Ophthalmol 2018; 196: 96-100.
[http://dx.doi.org/10.1016/j.ajo.2018.08.027] [PMID: 30153430]
[10]
Mir TA, Arham AZ, Fang W, et al. Acute vascular ischemic events in patients with central retinal artery occlusion in the United States: A nationwide study 2003-2014. Am J Ophthalmol 2019; 200: 179-86.
[http://dx.doi.org/10.1016/j.ajo.2019.01.009] [PMID: 30689989]
[11]
Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: Associated systemic and ophthalmic abnormalities. Ophthalmology 2009; 116(10): 1928-36.
[http://dx.doi.org/10.1016/j.ophtha.2009.03.006] [PMID: 19577305]
[12]
Sharma RA, Dattilo M, Newman NJ, Biousse V. Treatment of nonarteritic acute central retinal artery occlusion. Asia-Pac J Ophthalmol 2019; 7(4): 235-41.
[http://dx.doi.org/10.22608/APO.201871] [PMID: 29717825]
[13]
French DD, Margo CE, Greenberg PB. Ischemic stroke risk in medicare beneficiaries with central retinal artery occlusion: A retrospective cohort study. Ophthalmol Ther 2018; 7(1): 125-31.
[http://dx.doi.org/10.1007/s40123-018-0126-x] [PMID: 29574676]
[14]
Rim TH, Han J, Choi YS, et al. Retinal artery occlusion and the risk of stroke development. Stroke 2016; 47(2): 376-82.
[http://dx.doi.org/10.1161/STROKEAHA.115.010828] [PMID: 26742801]
[15]
Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: A scientific statement from the American Heart Association. Stroke 2021; 52(6): e282-94.
[http://dx.doi.org/10.1161/STR.0000000000000366] [PMID: 33677974]
[16]
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44(7): 2064-89.
[http://dx.doi.org/10.1161/STR.0b013e318296aeca] [PMID: 23652265]
[17]
Mac Grory B, Nackenoff A, Poli S, et al. Intravenous fibrinolysis for central retinal artery occlusion. Stroke 2020; 51(7): 2018-25.
[http://dx.doi.org/10.1161/STROKEAHA.119.028743] [PMID: 32568646]
[18]
Abel AS, Suresh S, Hussein HM, Carpenter AF, Montezuma SR, Lee MS. Practice patterns after acute embolic retinal artery occlusion. Asia-Pac J Ophthalmol 2017; 6(1): 37-9.
[http://dx.doi.org/10.22608/APO.201690] [PMID: 28161924]
[19]
Atkins EJ, Bruce BB, Newman NJ, Biousse V. Translation of clinical studies to clinical practice: Survey on the treatment of central retinal artery occlusion. Am J Ophthalmol 2009; 148(1): 172-3.
[http://dx.doi.org/10.1016/j.ajo.2009.03.020] [PMID: 19540987]
[20]
Youn TS, Lavin P, Patrylo M, et al. Current treatment of central retinal artery occlusion: A national survey. J Neurol 2018; 265(2): 330-5.
[http://dx.doi.org/10.1007/s00415-017-8702-x] [PMID: 29236169]
[21]
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24(1): 35-41.
[http://dx.doi.org/10.1161/01.STR.24.1.35] [PMID: 7678184]
[22]
Chodnicki KD, Pulido JS, Hodge DO, Klaas JP, Chen JJ. Stroke risk before and after central retinal artery occlusion in a US cohort. Mayo Clin Proc 2019; 94(2): 236-41.
[http://dx.doi.org/10.1016/j.mayocp.2018.10.018] [PMID: 30711121]
[23]
Lee KE, Tschoe C, Coffman SA, et al. Management of acute central retinal artery occlusion, a “Retinal Stroke”: An institutional series and literature review. J Stroke Cerebrovasc Dis 2021; 30(2): 105531.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105531] [PMID: 33310593]
[24]
Xiao YY, Wei WB, Wang YX, et al. Correlation of the history of stroke and the retinal artery occlusion: A nested case-control study. Int J Ophthalmol 2020; 13(3): 431-7.
[http://dx.doi.org/10.18240/ijo.2020.03.10] [PMID: 32309180]
[25]
Kido A, Tamura H, Ikeda HO, Miyake M, Hiragi S, Tsujikawa A. Nationwide incidence of central retinal artery occlusion in Japan: An exploratory descriptive study using the National Database of Health Insurance Claims (2011–2015). BMJ Open 2020; 10(9): e041104.
[http://dx.doi.org/10.1136/bmjopen-2020-041104] [PMID: 32973068]
[26]
Wu S, Wu B, Liu M, et al. Stroke in China: Advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019; 18(4): 394-405.
[http://dx.doi.org/10.1016/S1474-4422(18)30500-3] [PMID: 30878104]
[27]
Newman N, Biousse V. Diagnostic approach to vision loss. Continuum (Minneap Minn) 2014; 20(4): 785-815.
[http://dx.doi.org/10.1212/01.CON.0000453317.67637.46]
[28]
Scott IU, Campochiaro PA, Newman NJ, Biousse V. Retinal vascular occlusions. Lancet 2020; 396(10266): 1927-40.
[http://dx.doi.org/10.1016/S0140-6736(20)31559-2] [PMID: 33308475]
[29]
Tobalem S, Schutz JS, Chronopoulos A. Central retinal artery occlusion – rethinking retinal survival time. BMC Ophthalmol 2018; 18(1): 101.
[http://dx.doi.org/10.1186/s12886-018-0768-4] [PMID: 29669523]
[30]
Hoyer C, Kahlert C, Güney R, Schlichtenbrede F, Platten M, Szabo K. Central retinal artery occlusion as a neuro-ophthalmological emergency: The need to raise public awareness. Eur J Neurol 2021; 28(6): 2111-4.
[http://dx.doi.org/10.1111/ene.14735] [PMID: 33452753]
[31]
Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24(4): 493-519.
[http://dx.doi.org/10.1016/j.preteyeres.2004.12.001] [PMID: 15845346]
[32]
Michalinos A, Zogana S, Kotsiomitis E, Mazarakis A, Troupis T. Anatomy of the ophthalmic artery: A review concerning its modern surgical and clinical applications. Anat Res Int 2015; 2015: 591961.
[http://dx.doi.org/10.1155/2015/591961] [PMID: 26635976]
[33]
Mac Grory B, Lavin P, Kirshner H, Schrag M. Thrombolytic therapy for acute central retinal artery occlusion. Stroke 2020; 51(2): 687-95.
[http://dx.doi.org/10.1161/STROKEAHA.119.027478] [PMID: 31865896]
[34]
Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for central retinal artery occlusion in 2020: Time is vision! J Neuroophthalmol 2020; 40(3): 333-45.
[http://dx.doi.org/10.1097/WNO.0000000000001027] [PMID: 32739995]
[35]
Chatrath V, Banerjee PS, Goodman GJ, Rahman E. Soft-tissue filler–associated blindness. Plast Reconstr Surg Glob Open 2019; 7(4): e2173.
[http://dx.doi.org/10.1097/GOX.0000000000002173] [PMID: 31321177]
[36]
Nedelmann M, Graef M, Weinand F, et al. Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion. Stroke 2015; 46(8): 2322-4.
[http://dx.doi.org/10.1161/STROKEAHA.115.009839] [PMID: 26111890]
[37]
Ayrignac X, Zagroun C, Coget A, et al. Acute retinal arterial ischaemia: Silent brain infarcts prevalence and short-term recurrence. Eur J Neurol 2020; 27(12): 2517-22.
[http://dx.doi.org/10.1111/ene.14485] [PMID: 32810911]
[38]
Kang EYC, Lin YH, Wang NK, et al. Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: A retrospective cohort study in Taiwan. BMJ Open 2019; 9(2): e025455.
[http://dx.doi.org/10.1136/bmjopen-2018-025455] [PMID: 30819710]
[39]
Vestergaard N, Torp-Pedersen C, Vorum H, Aasbjerg K. Risk of stroke, myocardial infarction, and death among patients with retinal artery occlusion and the effect of antithrombotic treatment. Transl Vis Sci Technol 2021; 10(11): 2.
[http://dx.doi.org/10.1167/tvst.10.11.2] [PMID: 34468694]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy